AmplifyBio’s TCR Specificity Platform enhances TCR-T cell therapy development by integrating peptide positional flexibility assessment, comprehensive human proteome searches, tissue gene expression, in silico machine learning predictions, and cell-based assays.
AmplifyBio couples dedicated testing and related CRO services with a skilled team and access to the latest resources. This combination produces groundbreaking research for specialty products and assessments that can be analyzed for implementation in products and processes. Talk with us about your individual requirements and work with our specialists to develop an effective solution.
